EIT Pharma
Overview
Where EIT Pharma is now
EIT Pharma announced a Series A round of $35M on 31 August 2026, led by Propel Bio Partners.
Observed Described in the funding announcement as "biotechnology company focused on developing therapies for infectious diseases". Source
What happens next
What this raise plausibly creates
Likely next Moves
- Accelerated hiring across functions
- Repeatable go-to-market build
- First senior commercial hires
Opportunities this could create
- Clinical operations
- Regulatory affairs
- CMC and manufacturing
- Quality systems
- Medical affairs
Based on the Biotech & Pharma sector and a Series A round. Not a statement of fact.
- 31 August 2026$35M Series A announced
High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.
Momentum Inferred
AfterRaise Score
- Hiring momentum Open roles and hiring pace
- Market expansion New offices and new countries
- Leadership Executive appointments
- Product activity Launches and releases
Growth timeline
What has happened so far
- 31 August 2026$35M Series ALed by Propel Bio Partners.
Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.
Moves
Published by the company
No company-published Moves yet
AfterRaise has the funding facts for EIT Pharma from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.
Work here? Publish the first MoveOpportunities
Work this company has opened
No open Opportunities listed
Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.
Work here? Open the first oneOpen to
Who may approach EIT Pharma
Not yet specified
EIT Pharma has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.
Work here? Set your preferencesHelpful contributors
People who have contributed here
Nobody yet
When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.
Work here?
Own your growth story.
This room belongs to EIT Pharma. Claim it to tell people where you are going, confirm or correct what AfterRaise noticed, publish Moves, ask the network, control who can contact you, and share your growth story. Everything you publish is reviewed before it appears.
Also moving